[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
[procaare] WHO/WPRO ARV Newsletter No. 9
- From: ProCAARE <procaare@healthnet.org>
- Date: Mon, 29 Sep 2003 14:48:32 -0400 (EDT)
WHO/WPRO ARV Newsletter No. 9
**************************
Dear Colleagues:
WHO/WPRO is pleased to announce the release of the Antiretroviral Newsletter Issue No. 9.
The latest issue entitled Drug Resistance Part 2: Application to clinical practice"
focuses on the following:
* Summary of Resistance Testing Recommendations
* Types of Tests
* Interpreting Resistance Reports
* Laboratory Quality Assurance
* Evolving Patterns Resistance to Antiretroviral Drugs
* The Global HIV Drug Resistance Surveillance Network
This document is accessible on the Web through:
http://www.wpro.who.int/themes_focuses/theme1/focus4/pub_doc.asp
Hard copies can be obtained by requesting through e-mail or by writing to the address
below:
STI and HIV/AIDS Unit World Health Organization Western Pacific Regional Office
P.O. Box 2932 1000
Manila, Philippines
Tel: (632) 528 8001
Fax: (632) 521 1036
E-mail: HSI@wpro.who.int
Website: www.wpro.who.int
--
ProCAARE is currently supporting the 6th Home and Community Care
Conference in Dakar, Senegal (December 8 - 12, 2003).
For more information: http://www.dakarvih2003.sn/
To send a message to ProCAARE, write to: procaare@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe procaare OR unsubscribe procaare
To contact a person, send a message to: procaare-help@healthnet.org
Information and archives: http://www.procaare.org
The views presented in ProCAARE do not necessarily reflect the opinions of
SATELLIFE (http://www.healthnet.org), the Harvard AIDS Institute
(http://aids.harvard.edu), or Health & Development Networks
(http://www.hdnet.org), unless otherwise stated. The reader assumes all
responsibilities in using information posted or archived by ProCAARE.
Reproduction is welcomed, provided ProCAARE and procaare@healthnet.org
are quoted, and SATELLIFE is informed of usage.
|